NCT05131880

Brief Summary

Randomized controlled study that will include participants diagnosed with Parkinson's disease in mild or moderate stage with altered gait pattern who will be randomized following a simple randomization procedure in which one group will perform an intervention based on a gait re-education program called "TAPIZ FISIOR"- motor control and learning added to a conventional physiotherapy program; and the other group will perform only a conventional physiotherapy program. The evaluators will be unaware of the patient's treatment status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

November 8, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 23, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

September 9, 2025

Completed
Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

5 months

First QC Date

November 8, 2021

Results QC Date

May 27, 2025

Last Update Submit

September 5, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Physical Performance: The Short Physical Performance Battery (SPPB)

    The Short Physical Performance Battery (SPPB) assesses lower limb function and mobility through three subtests: standing balance (0-4), 4-m gait speed (0-4), and five-times chair rise (0-4). Subtest scores are summed for a total range of 0-12, with higher scores indicating better performance. The SPPB is widely used to detect mobility limitations, frailty, and disability risk, and has been proposed as an indicator of the mobility subdomain of intrinsic capacity.

    Before the intervention, up to 15 minutes; and at the end of 12 weeks intervention, up to 15 minutes.

  • Walk Speed: Timed Up and Go (TUG) Test

    The Timed Up and Go (TUG) test assesses basic mobility by measuring the time to stand from a chair, walk three meters, turn, return, and sit down. The time reflects walking speed, balance, turning ability, and overall functional mobility. Shorter times indicate better mobility, while longer times suggest slower gait and potential functional limitations.

    Before the intervention, up to 15 minutes; and at the end of 12 weeks intervention, up to 15 minutes.

  • Risk of Falls: FallSkip

    FallSkip is a validated tool for assessing fall risk using a portable inertial sensor placed on the lumbar spine. It evaluates parameters such as balance, gait, reaction time, and strength during standardized tasks. Results are integrated into a global score ranging from 0 (highest risk) to 100 (lowest risk), with higher scores indicating better performance and reduced fall risk.

    Before the intervention, up to 10 minutes; and at the end of 12 weeks intervention, up to 10 minutes.

  • Functionality and Independence: Barthel Index

    The Barthel Index is a validated scale measuring functionality and independence in activities of daily living (ADLs). It assesses 10 domains including feeding, bathing, dressing, mobility, and continence. Scores range from 0 (total dependence) to 100 (complete independence). Higher scores indicate greater functional autonomy, while lower scores reflect higher dependency and care needs.

    Before the intervention, up to 20 minutes.

Secondary Outcomes (1)

  • General Satisfaction

    At the end of 12 weeks intervention, up to 10 minutes.

Study Arms (2)

'TAPIZ FISIOR' gait re-education program combined with conventional physiotherapy program.

EXPERIMENTAL

The experimental group will undergo a physiotherapy program supplemented by the Fisior Mat Method, with three sessions per week over a 12-week period. Assessments will be conducted at baseline, immediately after the intervention, and at follow-up.

Other: Gait Re-education Program Using the Fisior® Mat Sequential Training System in Subjects with Parkinson's Disease

Conventional physiotherapy program

ACTIVE COMPARATOR

The control group will participate in a physiotherapy program three sessions per week for 12 weeks.

Other: Gait Re-education Program Using the Fisior® Mat Sequential Training System in Subjects with Parkinson's Disease

Interventions

Randomized controlled study that will include participants diagnosed with Parkinson's disease in mild or moderate stage with altered gait pattern who will be randomized following a simple randomization procedure in which one group will perform an intervention based on a gait re-education program called "TAPIZ FISIOR®"- motor control and learning added to a conventional physiotherapy program; and the other group will perform only a conventional physiotherapy program. The evaluators will be unaware of the patient's treatment condition.

'TAPIZ FISIOR' gait re-education program combined with conventional physiotherapy program.Conventional physiotherapy program

Eligibility Criteria

Age50 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older than 50 years.
  • Diagnosed Parkinson Disease.
  • Not to be institutionalized.
  • Barthel index scores of ≥ 60.
  • Ability to communicate and to get up and walk at least 10 m (33 ft)

You may not qualify if:

  • Medical criteria for contraindication of treatment.
  • Severe behavioral problems that hinder participation in the training program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alberto Bermejo Franco

Villaviciosa de Odón, Madrid, 28670, Spain

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Results Point of Contact

Title
Alberto Bermejo Franco
Organization
Universidad Europea de Madrid

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

November 8, 2021

First Posted

November 23, 2021

Study Start

November 1, 2021

Primary Completion

April 1, 2022

Study Completion

May 1, 2024

Last Updated

September 9, 2025

Results First Posted

September 9, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations